Additionally, in urothelial cancer cells, a depletion of progranulin reduced tumor cell growth in vivo in xenograft and orthotopic tumor models and suppression of granulin–epithelin precursor sensitized bladder cancer cells for cisplatin [42]. This evidence concerns the gene GRN and urinary bladder cancer.